According to epidemiological data, there are about 537 million adults with diabetes in the world, 90-95% of whom are those with type 2 diabetes, which presents a population to be addressed by more than 480 million people in the world
Some doctors might offer GLP-1 medications like Ozempic to fix this, but at Ovafit, we take a different approach
The Challenge of Real-World Implementation Barriers to replicating the frequent in-person weight checks seen in clinical trials in a typical outpatient setting include: Limited clinic availability and staff resources Patient inconvenience (e.g., travel, time off work) High volumes of new prescriptions and follow-ups These challenges create a gap between optimal monitoring and real-world practice one that remote weight monitoring is perfectly poised to fill
thereby rendering stools hard, dry, and highly painful to pass
Genetic deficiencies in the POMC-MC4R pathway leads to severe infantile obesity [5, 6]
Motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease